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Twenty-four-hour endocrine and metabolic profiles following
consumption of high-fructose corn syrup-, sucrose-, fructose-, and
glucose-sweetened beverages with meals1–3
Kimber L Stanhope, Steven C Griffen, Brandi R Bair, Michael M Swarbrick, Nancy L Keim, and Peter J Havel
ABSTRACT
Background: We have reported that, compared with glucose-
sweetened beverages, consuming fructose-sweetened beverages
with meals results in lower 24-h circulating glucose, insulin, and
leptin concentrations and elevated triacylglycerol (TG). However,
pure fructose and glucose are not commonly used as sweeteners.
High-fructose corn syrup (HFCS) has replaced sucrose as the pre-
dominant sweetener in beverages in the United States.
Objective: We compared the metabolic/endocrine effects of HFCS
with sucrose and, in a subset of subjects, with pure fructose and
glucose.
Design: Thirty-four men and women consumed 3 isocaloric meals
with either sucrose- or HFCS-sweetened beverages, and blood sam-
ples were collected over 24 h. Eight of the male subjects were also
studied when fructose- or glucose-sweetened beverages were con-
sumed.
Results: In 34 subjects, 24-h glucose, insulin, leptin, ghrelin, and TG
profiles were similar between days that sucrose or HFCS was con-
sumed. Postprandial TG excursions after HFCS or sucrose were
larger in men than in women. In the men in whom the effects of 4
sweeteners were compared, the 24-h glucose and insulin responses
induced by HFCS and sucrose were intermediate between the lower
responses during consumption of fructose and the higher responses
during glucose. Unexpectedly, postprandial TG profiles after HFCS
or sucrose were not intermediate but comparably high as after pure
fructose.
Conclusions: Sucrose and HFCS do not have substantially different
short-term endocrine/metabolic effects. In male subjects, short-term
consumption of sucrose and HFCS resulted in postprandial TG re-
sponses comparable to those induced by fructose. Am J Clin
Nutr 2008;87:1194–203.
INTRODUCTION
It has been suggested that the consumption of fructose, which
is consumed mainly in the form of high-fructose corn syrup
(HFCS) and sucrose, may be a contributing factor to the in-
creased incidence of obesity and metabolic syndrome (1, 2). The
current estimate for the mean intake of added sugars by Ameri-
cans is 15.8% of energy. However, this value is based on con-
sumption data from the 1994–1996 Continuing Survey of Food
Intakes by Individuals (CSFII) (3), and recent reports suggest
that energy intake from sugar-sweetened beverages alone ap-
proaches or exceeds 15% of calories in several population groups
(4–8). The large standard deviations in several of these reports
suggest that at least 16% of the studied populations were con-
suming 2 times the mean intake and likely well over 25% of
daily energy requirements from sugar-sweetened beverages (5,
7, 8). Based on these reports, it is reasonable to estimate that the
percentage of energy consumed as sugar from both beverages
and solid food is 20% in a significant portion of the US pop-
ulation.
We have reported that consuming fructose-sweetened bever-
ages with meals results in lower 24-h circulating glucose, insulin,
and leptin concentrations and decreased postprandial suppres-
sion of plasma ghrelin levels when compared with consumption
of glucose-sweetened beverages (9). We and others have re-
ported that consuming fructose-sweetened beverages increases
postprandial triacylglycerol (TG) concentration compared with
glucose-sweetened beverages (9–11). These responses are more
pronounced in men compared with women (10, 11) and in over-
weight/obese subjects compared with normal-weight subjects
(11). Because insulin, leptin, and possibly ghrelin function as key
signals to the central nervous system in the long-term regulation
of energy balance, prolonged consumption of diets high in en-
ergy from fructose could lead to increased caloric intake and
contribute to weight gain and obesity (2). The sustained elevation
of plasma TG concentrations after fructose ingestion suggests
that chronic overconsumption of fructose could also contribute to
atherogenesis and cardiovascular disease (12, 13). However,
pure fructose and pure glucose are not commonly employed as
sweeteners. Until a few decades ago, most foods and beverages
in the United States were sweetened with the disaccharide
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sucrose, which is composed of 50% glucose and 50% fructose. In
1970 an enzymatic process to convert corn sugar (composed of
glucose) into HFCS was developed. Since then, HFCS, mainly in
the form containing 55% fructose and 45% glucose, has replaced
sucrose as the predominant sweetener used in soft drinks and
represents40% of sweeteners added to foods consumed in the
United States (14).
Currently, there are few studies comparing the metabolic and
endocrine effects of HFCS with sucrose (15, 16), and, to our
knowledge, no studies comparing the effects of consuming
HFCS with pure fructose or glucose. The objectives of this study,
therefore, were to compare the metabolic and endocrine effects
of consuming HFCS- and sucrose-sweetened beverages and to
determine whether responses are affected by sex and adiposity. A
third objective was to compare the effects of consuming HFCS-
and sucrose-sweetened beverages with the consumption of bev-
erages sweetened with fructose or glucose.
SUBJECTS AND METHODS
Design
Circulating glucose, insulin, leptin, ghrelin, triacylglycerol
(TG), and free fatty acid (FFA) concentrations were measured in
34 subjects over a 24-h period on 2 separate days, during which
they consumed 3 isocaloric, mixed nutrient meals accompanied
by either sucrose-sweetened or HFCS-sweetened beverages. In a
subset of 8 male subjects, these variables were also measured on
2 additional days, during which these subjects consumed the
same isocaloric meals accompanied by beverages sweetened
with 100% fructose or 100% glucose.
Subjects
Thirty-four subjects (18 men and 16 women) with an age range
of 20–50 y (x 34.7 1.7 y) participated in the study. Participants
were recruited through newspaper advertisements and under-
went a telephone interview, a complete blood count, and a serum
biochemistry panel to assess eligibility. Respondents with ane-
mia, hepatic or renal disease, diabetes mellitus, fasting serum TG
levels 400 mg/dL, hypertension, eating disorders, or who had
surgery for weight loss were excluded from the study. Individ-
uals who smoked; who took thyroid, lipid-lowering, glucose-
lowering, antihypertensive, antidepressant, or weight-loss med-
ications; or who were pregnant or lactating were also excluded.
The Institutional Review Board of the University of California,
Davis, CA approved the experimental protocol, and subjects
provided informed consent to participate in the study.
Experimental protocol
Each subject participated in 2 experimental trials conducted in
random order. The experimental days were spaced 1 mo apart,
and each required an overnight stay in the University of Califor-
nia General Clinical Research Center (GCRC). During each ex-
perimental day the subjects consumed identical meals based on
calculated energy requirements (as described below) that in-
cluded beverages sweetened with either HFCS or sucrose. The 18
male subjects were invited to extend participation in the study,
and, of these, a subset of 8 men completed 2 additional study days
during which they consumed the identical meals accompanied by
beverages sweetened with either 100% fructose or glucose. Par-
ticipation in the additional fructose and glucose trials was limited
to male subjects because of budgetary constraints.
Percentage of body fat was determined by measurement of
bioelectrical impedance (Tanita 310GS Body Composition An-
alyzer; Tanita Corporation, Tokyo, Japan). Bioelectrical imped-
ance measurements of body fat in healthy adults has been shown
to correlate well with body fat measurements by dual-energy
X-ray absorptiometry (17, 18). As there is no consensus on the
percentage of body fat standards for overweight and obesity (19),
we used a statistical approach of dividing subjects of each sex
into 2 equal groups based on ranking by percentage of body fat.
Therefore, the men and women were divided into 2 groups with
lower and higher body adiposity based on a percentage of body
fat less than or greater than 22% and 32%, respectively.
The subjects were instructed to maintain their normal dietary
intake and level of physical activity during the interval between
the GCRC studies. Following a 12-h overnight fast, the subjects
checked into the GCRC at 0700. A physical examination was
conducted by the study physician, and an intravenous catheter
was inserted and kept patent with a slow saline infusion. Blood
sampling commenced at 0800 and continued for 24 h. Thirty-six
blood samples were collected for substrate and hormone mea-
surements over the 24-h sampling period during which the sub-
jects consumed 3 standardized meals. Each meal was accompa-
nied by a sucrose-, HFCS-, glucose-, or fructose-sweetened
beverage.
Meals
The meals consisted of whole foods and were designed by a
registered dietitian. The nutrient composition of the diets was
determined using the FOOD PROCESSOR SQL, (ESHA Re-
search Inc, Salem, OR). Each subject ingested 3 meals per day.
Breakfast consisted of scrambled eggs, ham, potatoes, and as-
paragus. Lunch consisted of chicken/tortilla soup with corn chips
and cheese. Dinner consisted of lasagna with beef and a salad
with lettuce, tomato, cucumber, celery, cheese, and vinaigrette
dressing. The energy content of the meals was based on each
subject’s daily energy requirement as estimated by the Mifflin
equation with an activity factor of 1.3 (20). The activity factor
was low because the subjects remained relatively sedentary
while at the GCRC. Twenty percent of the energy requirement
was consumed at breakfast, 35% at lunch, and 45% at dinner. The
meals contained 30% energy from fat, 15% from protein, 30%
from complex carbohydrate, and 25% from sugar. The 25% sugar
consisted of sucrose, HFCS, glucose, or fructose in the form of a
beverage. It is important to study the effects of sugars at the 25%
of energy intake level. The Institute of Medicine of the National
Academies, in the 2002 Dietary References Intakes, concluded
that there was insufficient evidence to set an upper-intake level
for added sugars because there were no specific adverse health
outcomes associated with excessive intake (21). Therefore, they
suggested a maximal intake level of 25% of energy intake from
added sugars. The sucrose and HFCS beverages were provided
by the sponsor (PepsiCo Inc, Purchase, NY) as 11% w:w sugar in
noncaffeinated carbonated sodas. The fructose and glucose were
prepared as 11% w:w solutions in carbonated soda water, fla-
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vored with a commercial unsweetened drink mix. The subjects
and GCRC study staff were blinded to the sweetener contained in
the beverages. The beverages were not matched for sweetness,
but, because the trials were spaced approximately 1 mo apart, it
is unlikely the subjects would have noticed a difference in the
sweetness of the beverages. The only other beverage served
during the 24-h study period was water. Breakfast was consumed
at 0900, lunch at 1300, and dinner at 1800. The subjects were
required to ingest all of the provided food and beverage within 20
min and were observed to ensure compliance.
Blood sampling
Blood samples were drawn from the catheters at 30-min in-
tervals around periods of meal ingestion and during the predicted
nocturnal rise of plasma leptin concentrations (ie, 5 h after the
evening meal) and at hourly intervals at other times (22). After
the 3 baseline samples, which were collected at 0800, 0830, and
0900 before ingestion of the first meal, a total of 33 additional
samples were collected 30–60 min apart. Each sample collection
involved the removal of 1 mL of blood to clear the catheter
tubing, followed by a 5 mL collection into blood-collection tubes
containing EDTA. Samples were then centrifuged, divided into
aliquots, and stored at80 °C until assayed.
Assays and data analysis
Plasma glucose and lactate concentrations were measured
with an automatic analyzer (YSI 2300 StatPlus Glucose Ana-
lyzer; Yellow Springs Instruments, Yellow Springs, OH). Insulin
and leptin concentrations were measured by radioimmunoassay
(Linco Research Inc, St Charles, MO). Total ghrelin concentra-
tions were measured in unextracted plasma with radioimmuno-
assay (Phoenix Peptide, Phoenix, AZ). TG concentrations were
measured with an automatic analyzer using manufacturer’s re-
agents (PolyChem Analyzer; PolyMedCo Inc, Cortlandt Manor,
NY). FFAs were measured with enzymatic colormetric reagents
(Wako Chemicals, Richmond, VA). Fasting lipid concentrations
were measured at baseline and at 0800 the following morning,
and apolipoprotein B100 (ApoB) concentrations were measured
at baseline and at 2200 with an automatic analyzer (PolyChem
Analyzer).
The area under the curve (AUC) was calculated for glucose,
insulin, ghrelin, FFA, and TG with a data spreadsheet program
(Microsoft EXCEL; Microsoft, Redmond, WA) using the trap-
ezoidal method. The mean of the 3 baseline values was deter-
mined, and net AUC was calculated by subtracting the areas
below baseline from AUC values above baseline. AUCs for
glucose, insulin, ghrelin, FFA, and TG are expressed as units per
23 h above each subject’s fasting baseline levels because the 3
samples taken during the first hour determined the baseline lev-
els. The nadirs for plasma leptin were determined as the 2 lowest
consecutive morning values before 1200 h, as described previ-
ously (22). The AUCs for leptin are therefore expressed as units
above each subject’s nadir over 24 h. Data from the 34 subjects
were analyzed with the statistical software program SPSS (ver-
sion 15.0; SPSS Inc. Chicago, IL) by using the general linear
model for repeated measures that included a sugar  adiposity
group sex interaction. Age was also included in the analysis,
with subjects grouped by 20–29, 30–39, and 40–50 y. Time was
included as a within-subject factor to assess change from fasting
levels in lipid concentrations. When the general linear model
results indicated the presence of a significant sugar effect or sex
or body adiposity interaction, paired and unpaired t tests were
performed within group, between men and women, or between
adiposity groups, respectively. Differences between the re-
sponses to the 4 sugars in the subset of 8 male subjects were
assessed with GRAPHPAD PRISM (version 4.03; San Diego,
CA, USA) using repeated-measures, one-factor ANOVA, and
posttests were performed using Tukey’s test for multiple com-
parisons.
RESULTS
Baseline measures
The age, body weight, percentage of body fat, and body mass
index of the subjects are presented in Table 1. Body weight and
baseline fasting plasma concentrations of glucose, hormones,
and lipids are shown in Table 2 for the sucrose and HFCS study
days. Fasting TG and apoB concentrations were lower in women
(14.1 6.5 and12.1 4.2 mg/dL, respectively; P 0.05,
paired t test) and higher in men (12.0 5.1 and 6.9 3.4 mg/dL,
respectively; P  0.05, paired t test) on the day of the sucrose
feeding compared with the day of the HFCS feeding. There were
no differences in baseline concentrations of the other measured
parameters on the 2 study days.
Effects of HFCS and sucrose with 24-h profiles
Twenty-four-hour plasma profiles of glucose, leptin, ghrelin,
TG, and FFA concentrations, as assessed by AUC, were not
different on the days that HFCS-sweetened beverages were con-
sumed with meals compared with when sucrose-sweetened bev-
erages were consumed (Figure 1, Table 3). The insulin AUC
was slightly but significantly increased by consumption of
sucrose-sweetened beverages compared with HFCS-sweetened
TABLE 1
Age, body weight, and adiposity of study participants1
Women32 %BF
(n 8)
Women32 %BF
(n 8)
Men22 %BF
(n 9)
Men22 %BF
(n 9)
Men 4-Sugar Subset
(n 7)
Age (y) 29.1 3.6 39 3 38 4 31 3 37.1 4.3
BW (kg)2 60.2 1.7 76.4 4.03 73.7 3.0 88.5 3.63 82.0 5.2
Body fat (%)2 25.7 1.4 39.2 1.74 18.3 1.1 25.1 1.14 21.0 2.5
BMI (kg/m2)2 21.9 0.6 28.9 1.64 24.3 0.5 28.0 0.74 26.1 1.0
1 All values are xSEM. Within gender groups, subjects were ranked by %BF (body fat) and divided into 2 equal groups. General linear model–Univariate
with gender and adiposity group as fixed factors.
2 P 0.0001 for differences among the 4 gender/weight groups.
3, 4 Within gender unpaired t tests for adiposity group differences: 3P 0.01, 4 P 0.001.
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beverages. This difference was significant in subjects younger
than 35 y (n 17; P 0.01) but not significant in subjects older
than 35 y (n 17; P 0.5).
Effects of HFCS and sucrose on changes of fasting lipid
concentrations
There were no differences between the effects of consuming
sucrose- or HFCS-sweetened beverages with 3 meals on changes
in fasting lipid concentrations from baseline to the following
morning (0800 h) for plasma TG, cholesterol, LDL, or HDL
concentrations, and on changes between baseline and postpran-
dial concentrations of ApoB at 2200 h (Table 4). Consumption
of both sucrose and HFCS significantly increased fasting TG
concentrations the following morning (sucrose: 28.3  5.4
mg/dL, P 0.001; HFCS:18.9 4.5 mg/dL, P 0.001) and
decreased postprandial ApoB concentrations at 2200 (sucrose:
5.8 1.3 mg/dL, P 0.001; HFCS:6.0 1.9 mg/dL, P
0.01).
Effects of HFCS- and sucrose-sweetened beverages in
men and women and in adiposity groups
The 24-h AUCs of glucose, insulin, leptin, ghrelin, TG, or FFA
were not significantly different between the lower and higher
adiposity groups. The 24-h leptin AUC in women was3 times
higher than in men (P 0.01, unpaired t test) during consump-
tion of both HFCS and sucrose (Table 3, Figure 2A). There was
a marked sex difference in 24-h TG AUC, with a mean AUC
during sucrose consumption 3 times higher (P0.01) and during
HFCS consumption 7 times higher (P 0.001, unpaired t test) in
men than in women (Table 3, Figure 2B). The AUC for FFA was
less suppressed (ie, less negative) in men compared with women
(Table 3), with the effect being statistically significant during
HFCS consumption (men:2.6 0.3 mmol/L  23 h; women:
4.5  0.6 mmol/L  23 h; P  0.05) but not during sucrose
consumption (men:2.3 0.3 mmol/L  23 h; women:3.7
0.7 mmol/L  23 h; NS, unpaired t test).
TABLE 2
Baseline body weight and fasting plasma concentrations of glucose, hormones, and lipids on each study day1
All
(n 34)
Women32 %BF
(n 8)
Women32 %BF
(n 8)
Men22 %BF
(n 9)
Men22 %BF
(n 9)
Body Weight (kg)
Sucrose 75.2 2.4 60.1 1.7 76.1 4.2 74.0 3.0 89.0 3.5
HFCS 74.9 2.3 60.2 1.7 76.6 3.8 73.4 2.9 88.0 3.6
Glucose (mg/dL)
Sucrose 88.0 1.4 82.5 1.4 86.4 2.3 89.5 2.3 92.9 3.7
HFCS 86.8 1.4 81.5 1.8 84.6 2.8 87.7 1.2 92.6 3.3
Insulin (U/mL)
Sucrose 11.6 1.2 9.5 0.6 14.9 2.7 7.6 1.2 14.4 3.4
HFCS 11.4 1.3 9.2 0.7 14.8 2.9 7.3 0.9 14.5 3.6
Leptin (ng/mL)
Sucrose 10.8 1.6 8.5 1.4 23.7 3.9 3.6 0.4 8.6 1.3
HFCS 10.1 1.4 8.3 1.1 20.9 2.9 3.5 0.5 8.5 1.5
Ghrelin (pg/mL)
Sucrose 441.0 36.4 613.2 111.3 414.9 60.6 396.7 50.9 355.6 31.9
HFCS 435.4 30.6 590.0 75.2 398.9 66.5 399.8 47.7 365.9 29.9
TG (mg/dL)2
Sucrose 107.7 10.4 78.2 9.7 94.5 16.0 106.1 20.9 147.1 25.9
HFCS 109.2 9.1 98.9 12.2 102.9 10.23 92.0 17.5 135.5 23.63
FFA (mEq/L)
Sucrose 0.34 0.02 0.39 0.06 0.39 0.04 0.30 0.05 0.30 0.03
HFCS 0.37 0.02 0.41 0.05 0.43 0.04 0.32 0.04 0.32 0.03
Cholesterol (mg/dL)4
Sucrose 176.1 5.5 153.4 6.0 181.8 14.5 186.4 9.0 180.9 11.0
HFCS 176.8 5.7 156.9 4.2 199.4 13.95 175.8 11.0 175.6 10.75
LDL (mg/dL)
Sucrose 107.7 4.4 86.1 5.9 106.6 8.8 120.9 7.8 114.7 8.9
HFCS 108.0 5.1 85.9 5.7 120.0 12.8 113.8 10.4 111.3 8.0
HDL (mg/dL)
Sucrose 47.0 1.8 51.6 3.9 56.1 3.2 44.3 2.2 37.3 1.2
HFCS 47.4 1.9 52.0 3.7 58.4 3.8 44.0 1.7 37.1 1.6
ApoB (mg/dL)6
Sucrose 76.4 4.4 56.3 4.9 72.3 8.9 95.1 6.2 79.4 9.6
HFCS 77.6 4.3 60.6 5.3 88.5 9.33 87.0 8.5 73.7 8.63
1 All values are x  SEM. General linear model for repeated measures for the interaction of sugar and gender, adiposity and age group.
2 Sugar, P 0.37; Sugar Gender, P 0.001; Sugar Age, P 0.012; Sugar Gender weight Age, P 0.019.
3,5 Significant Sugar Gender differences tested for within gender group difference by paired t test: 3 P 0.05, 5 NS.
4 Sugar, P 0.83; Sugar Gender, P 0.038.
6 Sugar, P 0.76; Sugar Gender, P 0.0034.
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Effects of HFCS-, sucrose-, fructose- and glucose-
sweetened beverages
One of the male subjects who participated in 4 of the 24-h blood
collections while consuming sucrose, HFCS, fructose, or glucose
had mild hypertriacylglycerolmia (fasting [TG]  196 mg/dL);
therefore, this subject’s results were not included in the final anal-
yses.SeeFigureS1under“SupplementalData” in thecurrentonline
issue for the 24-h profile graphs from this subject. The characteris-
tics of the 7 male subjects with normal fasting TG concentrations
(150 mg/dL, US National Cholesterol Education Program Guide-
line) are presented in Table 1. There were no significant differences
in body weight or baseline concentrations of any of the measured
parameters across the 4 study days (Table 5).
The effects of the 4 sugars on 24-h AUC were significantly dif-
ferent for glucose (P 0.010), insulin (P 0.0001), and TG (P
0.007) by repeated-measure, one-factor ANOVA, while there were
no differences in the AUCs for leptin, ghrelin, or FFA (Figure 3,
Table 6).
Consumption of fructose-sweetened beverages resulted in
glucose and insulin AUCs that were significantly lower than the
AUCs induced by glucose consumption (P  0.01, P  0.001
glucose and insulin, respectively, Tukey’s posttest). As ex-
pected, consumption of the HFCS- and sucrose-sweetened bev-
erages resulted in glucose and insulin AUCs that tended to be
intermediate between the higher AUCs induced by glucose con-
sumption and the lower AUCs induced by fructose. However, the
glucose AUCs were lower during consumption of sucrose and
HFCS than would be expected based on the relative glucose
concentrations of the 4 beverages. The 24-h AUCs for plasma
glucose concentrations averaged 76% of the expected AUC (x of
the glucose AUCs during fructose and glucose consumption)
during sucrose consumption, and 81% of the expected AUC
(0.55 fructose x  0.45 glucose x) during HFCS consump-
tion. Accordingly, the insulin AUCs during sucrose and HFCS
consumption were also lower than expected (84% of the expected
value for sucrose; 83% of expected value for HFCS). The 24-h
postprandial TG profiles on the days the subjects consumed
HFCS or sucrose were not intermediate between those of glucose
and fructose as expected but were comparable to the magnitude
of the profile following consumption of 100% fructose beverages
FIGURE 1. Plasma glucose (A), insulin (B), triacylglycerol (E), and free fatty acid (F) concentrations during a 24-h period (0800–0800) in 34 women and
men consuming HFCS- or sucrose-sweetened beverages with each meal. Change () in plasma leptin (C) over the morning nadir and ghrelin concentrations
(D) from mean baseline levels (0800–0900) during a 24-h period (0800–0800) in 34 women and men consuming HFCS- or sucrose-sweetened beverages with
each meal. Data shown as mean SEM.
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(Figure 3D). The TG 24-h AUC during HFCS consumption was
significantly higher than the AUC during glucose consumption
(P 0.01, Tukey’s posttests) (Table 6).
Consumption of all 4 sugar-sweetened beverages with meals also
resulted in significant increases in the fasting TG concentrations the
following morning (0800 h), but there were no differences
among the effects of the 4 sugars. Similarly, all 4 sugars de-
creased postprandial ApoB concentrations (2200 h); however,
the sugar  time interaction was not statistically significant
(Table 7).
TABLE 3
24-h AUC of endocrine/metabolic variables during consumption of sucrose- and HFCS-sweetened beverages with meals1
All
(n 34)
Women32 %BF
(n 8)
Women32 %BF
(n 8)
Men22 %BF
(n 9)
Men22 %BF
(n 9)
Glucose (mg/dL,23hr)
Sucrose 222.2 27.2 278.7 41.1 243.0 55.6 209.6 41.7 166.2 72.6
HFCS 226.8 25.2 299.6 40.4 276.0 46.5 210.5 52.4 134.6 47.0
Insulin (U/mL,23hr)3
Sucrose 381.1 48.9 321.2 64.5 544.3 164.4 237.7 31.6 432.6 75.7
HFCS 344.4 43.3 255.0 42.9 515.9 148.9 221.1 25.3 394.8 59.5
Leptin (ng/mL,24hr)4
Sucrose 57.0 10.4 56.4 18.0 120.1 28.2 19.2 3.9 39.3 11.36
HFCS 57.2 9.5 61.3 13.8 117.6 24.4 18.6 5.0 38.5 11.27
Ghrelin (pg/mL,23hr)
Sucrose 933.6 234.8 1,677.9 786.1 841.1 294.2 685.9 350.1 602.0 323.9
HFCS 897.2 188.1 1,331.7 358.4 547.2 496.6 946.2 341.2 773.2 326.7
TG (mg/dL,23hr)5
Sucrose 793.3 135.8 359.5 153.1 398.7 145.3 1,017.3 344.5 1,305.8 238.46
HFCS 611.1 132.1 29.2 184.2 315.2 257.2 978.2 177.4 1,076.2 251.87
FFA (mEg/L,23hr)4
Sucrose 3.0 0.4 3.7 1.1 3.8 0.9 2.4 0.6 2.2 0.38
HFCS 3.5 0.4 4.3 1.1 4.7 0.8 2.3 0.5 2.8 0.36
1 All values are x  SEM. General linear model for repeated measures for the interaction of sugar and gender, adiposity and age group.
3 Sugar, P0.016; SugarAge, P0.001. SugarAge interaction for insulin tested for within age group difference by paired t test (cutoff 35 y; n17/group).
Subjects 35 y: Mean insulin AUC 398.5 53.4U/mL23hr sucrose, 310.6 39.4U/mL23hr HFCS, P 0.0011. Subjects 35 y: Mean insulin AUC
 363.6 83.5 U/mL23hr sucrose, 378.2 77.7 U/mL23hr HFCS, P 0.51. All other Sugar between subject factors, P 0.05.
4 ,5 Gender difference by general linear model (4P 0.05, 5 P 0.01).
6 ,7,8 Variables with significant gender differences tested for between gender group differences by paired t test (Female, n 16; Male, n 18; 6P 0.01, 7 P
0.001, 8 NS). All other between subject factors and 2- and 3-way interactions, P 0.05.
TABLE 4
Absolute change from baseline lipid concentrations after consumption of sucrose- and HFCS-sweetened beverages with meals1
All Subjects
(n 34)
Women32 %BF
(n 8)
Women32 %BF
(n 8)
Men22 %BF
(n 9)
Men22 %BF
(n 9)
TG (mg/dL)2,4
Sucrose 28.3 5.4 15.2 4.1 29.5 9.5 19.0 9.6 48.3 14.1
HFCS 18.9 4.5 2.8 7.1 16.8 6.6 36.6 9.5 22.3 8.1
Cholesterol (mg/dL)
Sucrose 2.4 2.8 5.3 6.0 2.9 4.5 1.1 6.3 12.1 4.7
HFCS 1.1 2.5 7.5 7.1 5.8 5.3 3.2 3.2 2.3 3.9
LDL (mg/dL)
Sucrose 2.9 1.9 5.1 4.1 4.0 3.1 3.6 5.0 0.9 2.7
HFCS 2.5 1.7 4.4 4.0 0.8 3.7 3.7 2.8 2.4 3.2
HDL (mg/dL)
Sucrose 0.4 0.8 3.1 2.3 1.3 1.6 1.4 1.1 1.4 1.0
HFCS 0.6 0.8 3.3 2.2 1.6 1.7 0.9 1.2 0.1 1.3
ApoB (mg/dL)3,4
Sucrose 5.8 1.3 5.9 1.1 3.75 10.7 3.7 2.8 2.2
HFCS 6.0 1.9 10.5 4.4 5.25 5.9 2.6 2.8 3.5
1 All values are x  SEM. General linear model for repeated measures for the interaction of sugar and gender, adiposity and age group. TG, Cholesterol,
LDL, HDL: Concentration at 0800h the following day minus baseline concentration. ApoB: Concentration at 2200h (4 h after dinner) minus baseline
concentration.
2 Sugar, P 0.43; Time, P 0.0001; Sugar Time, P 0.23.
3 Sugar, P 0.81; Time, P 0.0001; Sugar Time, P 0.89.
4 All Sugar Time Between Subject Factors, P 0.05.
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DISCUSSION
Effects of HFCS and sucrose
The 24-h postprandial glucose, leptin, and ghrelin profiles
during the consumption of HFCS-sweetened beverages were not
significantly different from those when sucrose-sweetened bev-
erages were consumed. These results are similar to those of
Melanson et al (16), who investigated sucrose and HFCS con-
sumption at 30% of energy by 30 normal-weight women. Our
results extend their findings to men and to overweight and obese
subjects. The insulin AUC was slightly but significantly in-
creased during consumption of sucrose- compared with HFCS-
sweetened beverages. This increase was not unexpected given
that sucrose contains 10% more glucose than HFCS; however,
Melanson et al (16) did not report a similar increase in their study.
Consumption of HFCS and sucrose also resulted in similar 24-h
TG and FFA AUCs, variables that were not examined in that
study.
Fasting plasma TG concentrations at 0800 h the following
morning were increased compared with baseline levels after both
sucrose and HFCS consumption. In the subset of 7 men, con-
sumption of all 4 sugars resulted in significant increases of fast-
ing TG the following morning. These increases in fasting TG
induced by 24-h exposure to sugar-sweetened beverages may be
transitory. We and other investigators have reported that long-
term consumption (	2 wk) of fructose at 20–25% of energy did
not increase fasting TG concentrations in healthy subjects (23),
in older overweight and obese subjects (24, 25), in hyperinsu-
linemic female subjects (26), and in patients with type 2 diabetes
(27, 28) or hypertriacylglycerolemia (29). However, in other
studies, 2 or more weeks of fructose consumption at 15–20% of
energy increased fasting TG concentrations in healthy subjects
(10, 30–32), in hyperinsulinemic male subjects (32, 33), and in
subjects with type 2 diabetes (34). The reasons underlying these
conflicting results are not clear. Interestingly, postprandial con-
centrations of ApoB, measured 4 h after dinner, were signifi-
cantly decreased compared with baseline levels following con-
sumption of HFCS or sucrose in the 34 subjects and following
consumption of all 4 sugars in the subset of 8 male subjects.
These data also contrast with results from our 2 long-term studies
in which consumption of fructose-sweetened beverages for 10
wk increased both fasting and postprandial ApoB concentra-
tions, whereas consuming glucose-sweetened beverages did not
(24, 25). These differences in the effects of short-term and long-
term sugar exposure on ApoB and fasting TG concentrations
demonstrate the need for long-term studies with both fasting and
postprandial measurements to determine the metabolic effects of
prolonged daily consumption of sugar-sweetened beverages.
Effects of sex-specific differences
The higher leptin AUC in women compared with men was not
unexpected, as sex-specific differences in leptin are well estab-
lished (35, 36). Men had higher postprandial TG responses than
women, and this difference has been demonstrated previously by
us (11) in a 24-h study of overweight and obese men and pre-
menopausal women. Bantle et al (10) reported that men had
increased postprandial TG levels during consumption of a
6-week, 17%-of-energy fructose diet, but this was not observed
FIGURE 2. Change () in plasma leptin concentrations (A) over the morning nadir during a 24-h period (0800–0800) in 16 women and 18 men consuming
HFCS- or sucrose-sweetened beverages with each meal. Plasma triacylglycerol concentrations (B) during a 24-h period (0800–0800 h) in 16 women and 18
men consuming HFCS- or sucrose-sweetened beverages with each meal. Data shown as mean SEM.
TABLE 5
Baseline body weight and plasma concentrations of glucose, hormones, and lipids on each study day in 7 men1
Beverage Body weight Glucose Insulin Leptin Ghrelin TG FFA
kg mg/dL U/mL ng/mL pg/mL mg/dL mEq/L
Glucose 82.4 5.52 92.0 1.5 9.2 1.3 5.4 1.1 316.6 76.3 91.4 11.0 0.32 0.04
Fructose 81.3 5.8 93.7 2.1 10.2 2.1 5.5 1.3 316.9 73.3 102.0 13.6 0.34 0.04
Sucrose 82.0 5.6 93.5 2.4 10.5 1.5 4.8 1.0 312.6 53.6 96.7 9.0 0.26 0.04
HFCS 81.5 5.6 90.3 2.4 9.0 1.7 4.8 1.3 306.3 52.4 87.4 9.0 0.29 0.04
Repeated-measures
1-factor ANOVA
P 0.50 0.39 0.56 0.56 0.98 0.47 0.10
1 There were no significant differences in baseline body weight and plasma concentrations of glucose, hormones, and lipids on the 4 study days.
2 x  SEM (all such values).
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in women. Thus, available data suggest that men are more sus-
ceptible than women to the effects of sugars containing fructose
to increase plasma TG concentrations. Whether this sex-specific
difference exists in older males compared with postmenopausal
female subjects remains to be determined.
Effects of fructose, glucose, sucrose, and HFCS
As expected, the responses of circulating glucose and insulin
induced by consumption of sucrose and HFCS were relative to
their glucose and fructose contents, thus intermediate to the
larger responses induced by glucose and the lower responses
after fructose. We had expected that the TG profiles would be
directly related to the fructose content of the beverages con-
sumed. We and Bantle et al (9–11, 25) have demonstrated pre-
viously that fructose consumption increases postprandial TG
compared with glucose consumption. A likely mechanism is
increased hepatic de novo lipogenesis (DNL), which has been
reported to increase markedly during fructose ingestion com-
pared with glucose ingestion (37).
In the 7 male subjects who participated in the comparison of all
4 sugars, the 24-h postprandial TG responses to HFCS and su-
crose were not intermediate between those induced by fructose
and glucose. Sucrose and HFCS resulted in postprandial TG
responses that were comparable to pure fructose alone, and con-
sumption of HFCS-sweetened beverages significantly increased
24-h TG AUCs compared with glucose.
It is possible the mechanism by which sucrose and HFCS
increase postprandial TG comparably to pure fructose may in-
volve fructose-stimulated hepatic glucose uptake. Low-dose IV
infusion of fructose has been reported to increase portal uptake of
glucose in dogs (38), and oral fructose has been shown to lower
peripheral plasma glucose responses to oral glucose ingestion in
humans (39). Data from the present study suggest that additional
glucose, when consumed concurrently with fructose, may have
FIGURE 3. Plasma glucose (A) and insulin (B) concentrations during a 24-h period (0800–0800 h) in 7 men consuming HFCS-, sucrose-, fructose-, and
glucose-sweetened beverages with each meal. Change () in plasma leptin concentration (C) over the morning nadir and plasma triacylglycerol (D) concen-
trations from mean baseline levels (0800–0900) during a 24-h period (0800–0800) in 7 men consuming HFCS-, sucrose-, fructose-, and glucose-sweetened
beverages with each meal. Data shown as mean SEM.
TABLE 6
24-h AUC of endocrine/metabolic variables during consumption of sucrose-, HFCS-, fructose-, and glucose-sweetened beverages with meals in 7 men
Beverage Glucose Insulin Leptin Ghrelin TG FFA
mg  dL1  23h1 U  mL1  23h1 ng  mL1  24h1 pg  mL1  23h1 mg  dL1  23h1 mEq  L1  23h1
Glucose 344.6 73.71 399.6 58.5 29.7 10.1 874.1 614.1 458.3 89.1 1.8 0.6
Fructose 113.8 53.72 181.8 20.03 14.9 6.7 1,120.8 634.1 751.2 150.2 2.7 0.5
Sucrose 175.1 48.9 242.7 33.23 19.2 5.2 570.0 311.4 738.7 170.7 1.6 0.5
HFCS 177.7 79.0 230.6 42.93 13.5 3.7 640.2 422.2 1,043.5 132.02 2.0 0.4
Repeated-measures
1-factor ANOVA
P 0.010 0.0001 0.081 0.27 0.0065 0.31
1 x  SEM (all such values).
2 P 0.01, 3 P 0.001 compared to glucose (reference) using the Tukey’s Multiple Comparison Test.
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been taken up and metabolized in the liver. The consumption of
sucrose and HFCS resulted in 24-h glucose and insulin AUCs
that were less than would be expected relative to their glucose and
fructose content and the AUCs measured during consumption of
the beverages sweetened with 100% glucose or fructose.
Activation of sterol receptor element binding protein-1c
(SREBP-1c), the major transcriptional regulator of fatty acid
synthesis, may also contribute to the larger-than-expected post-
prandial TG responses during sucrose and HFCS consumption.
Matsuzaka et al (40) have reported that glucose, fructose, and
sucrose increased hepatic SREBP-1c mRNA expression inde-
pendently of insulin in streptozotocin-diabetic mice. Interest-
ingly, they found that the timing of the SREBP-1c up-regulation
varied following sugar feeding. Glucose and sucrose feeding
induced maximal expression of SREBP-1c within 6 h (4- to
7-fold increase), while maximal expression following fructose
feeding occurred at 12 h (5-fold increase) (40).
Results from our 2 studies comparing the long-term (10 wk)
effects of fructose and glucose consumption demonstrate that the
marked postprandial hypertriacylglycerolemia induced by fruc-
tose consumption is not a transitory response (24, 25). Similar
studies are needed to determine whether the postprandial hyper-
triacylglycerolemia induced by HFCS and sucrose consumption
is also maintained with more prolonged exposure. There is grow-
ing evidence to link postprandial lipemia with proatherogenic
conditions (12, 13, 41–44). Two recent articles provide clinical
evidence to support the association between elevated concentra-
tions of postprandial TG and increased risk of cardiovascular
disease. In a prospective cohort study of 7587 women and 6394
men followed for 26 y, elevated nonfasting TG levels were as-
sociated with increased risk of myocardial infarction, ischemic
heart disease, and death (13). In the Women’s Health Study,
26 509 women were followed for 11 y (12). Nonfasting TG
levels, but not fasting levels, were associated with incident car-
diovascular events independent of traditional cardiac risk fac-
tors, levels of other lipids, and markers of insulin resistance (12).
In both of these studies there was a significant linear relation
between increased nonfasting TG and increased hazard ratio for
all outcomes (12, 13).
Conclusions
While consumption of sucrose compared with HFCS-
sweetened beverages induced a small increase in the 24-h insulin
AUC in 34 subjects, the effects of sucrose and HFCS on 24-h
circulating glucose, leptin, and ghrelin concentrations were not
otherwise different. Thus, it appears that sucrose and HFCS do
not have substantially different short-term effects on endocrine
signals involved in body-weight regulation. Consumption of
HFCS beverages also did not increase postprandial TG levels to
a greater extent than those observed during consumption of
sucrose-sweetened beverages.
Comparison of the effects of glucose, fructose, sucrose, and
HFCS beverages within the same male subjects demonstrated
that postprandial glucose and insulin responses were intermedi-
ate between the lower responses induced by pure fructose and the
larger responses induced by pure glucose. Unexpectedly, the
effects of short-term consumption of HFCS and sucrose on post-
prandial TG levels were not intermediate to those of fructose and
glucose but comparable to fructose alone. Studies to determine
whether these high postprandial TG levels are sustained during
long-term consumption of sucrose and HFCS are needed. Addi-
tional studies in women and in subjects with and without com-
ponents of the metabolic syndrome, as well as dose-response
studies, are needed to more fully understand the metabolic effects
of fructose-containing sugars.
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